Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. Genetic heterogeneity, therapeutic hurdle confronting sorafenib and immune checkpoint inhibitors in hepatocellular carcinoma

- Atwa S.M. , et al.

2. MDR1 gene C3435T polymorphism in chronic hepatitis C patients

- Parsa Nahad M. , et al.

3. Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study

- Tandia M. , et al.

4. Frequency of the MDR1 gene polymorphism rs1045642 (C3435T) in HCV-HIV co-infected patients

- Marasca G.d.S. , et al.

5. Common ABCB1 polymorphisms in Greek patients with chronic hepatitis C infection: A comparison with hyperlipidemic patients and the general population

- Gbandi E. , et al.

6. Characterisation of selected molecular mechanisms influencing pharmacokinetics and pharmacodynamics of antidepressants

- Jeleń A. , et al.

7. The ABCB1-C3435T polymorphism likely acts as a risk factor for resistance to antiepileptic drugs

- Li M. , et al.